Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-25T13:08:03.464Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutritional advantages of probiotics and prebiotics

Published online by Cambridge University Press:  09 March 2007

P. Marteau  and
M. C. Boutron-Ruault
P. Marteau*
Affiliation:
ISTNA (INSERM U557-INRA U1125-EA CNAM 3200), Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, France Gastroenterology Department, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, France Paris V University, France
M. C. Boutron-Ruault
Affiliation:
ISTNA (INSERM U557-INRA U1125-EA CNAM 3200), Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, France Gastroenterology Department, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, France
*
*Corresponding author:Professor P. Marteau, Service d'Hépato-Gastroentérologie, Hôpital Européen Georges Pompidou 20 rue Leblanc, 75908 Paris CEDEX 15, France, fax +33 1 5609 3554, email philippe.marteau@egp.ap-hop-paris.fr
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The potential ‘nutritional advantages’ of probiotics and prebiotics consist of preventive, and sometimes curative, effects against certain diseases. The evidence supporting such advantages, which requires randomised controlled trials and consistency of results from study to study, is rapidly increasing. This article summarizes the effects against diseases of intestinal origin. There is a high level of evidence for positive effects of some prebiotics to alleviate constipation and treat hepatic encephalopathy. Interesting aspects, but with a lower level of evidence at the present time, include prevention of colon cancer, intestinal infection, and recurrence of inflammatory bowel disease. There is a high level of evidence for positive effects of some probiotics in the alleviation of lactose intolerance, antibiotic-associated intestinal disorders and gastroenteritis. Evidence is rapidly growing regarding the prevention of recurrence of inflammatory bowel diseases. Positive trials have suggested preventive effects against intestinal colonization with specific gut pathogens including Clostridium difficile and Helicobacter pylori.

Keywords

ProbioticsPrebioticsDisease prevention by food
Type
Research Article
Information
British Journal of Nutrition , Volume 87 , Issue S2 , May 2002 , pp. S153 - S157
Copyright
Copyright © The Nutrition Society 2002

References

Armuzzi, A, Cremonini, F, Bartolozzi, F, Canducci, F, Candelli, M, Ojetti, V, Cammarota, G, Anti, M, De Lorenzo, A, Pola, P & Gasbarrini, G & Gasbarrini, A (2001) The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics 15, 163–169.CrossRefGoogle ScholarPubMed
Bouglé, D, Roland, N, Lebeurrier, F & Arhan, P (1999) Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects. Scandinavian Journal of Gastroenterology 34, 144–148.Google Scholar
Boutron, MC, Faivre, J, Marteau, P, Couillault, C, Senesse, P & Quipourt, V (1996) Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case–control study. British Journal of Cancer 74, 145–151.CrossRefGoogle ScholarPubMed
Campieri, M, Rizzello, F, Venturi, A, Poggioli, G, Ugolini, F & Helwig, U et al. , (2000) Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine (abstract). Gastroenterology 118, G4179.CrossRefGoogle Scholar
Canducci, F, Armuzzi, A, Cremonini, F, Cammarota, G, Bartolozzi, F, Pola, P, Gasbarrini, G & Gasbarrini, A (2000) A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Alimentary Pharmacology and Therapeutics 14, 1625–1629.CrossRefGoogle ScholarPubMed
Clausen, MR & Mortensen, PB (1997) Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs 53, 930–942.CrossRefGoogle ScholarPubMed
Coconnier, MH, Lievin, V, Hemery, E & Servin, AL (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Applied and Environmental Microbiology 64, 4573–4580.CrossRefGoogle ScholarPubMed
Copaci, I, Micu, L, Chira, C & Rovinaru, I (2000) Maintenance of remission of ulcerative colitis (UC): mesalamine, dietary fiber, S boulardii (abstract). Gut 47 (suppl III), A240–P929.Google Scholar
Czerucka, D, Dahan, S, Mograbi, B, Rossi, B & Rampal, P (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infection and Immunity 68, 5998–6004.CrossRefGoogle ScholarPubMed
Dai, D & Walker, WA (1999) Protective nutrients and bacterial colonization in the immature human gut. Advances in Pediatrics 46, 353–382.CrossRefGoogle ScholarPubMed
de Vrese, M, Stegelmann, A, Richter, B, Fenselau, S, Laue, C & Schrezenmeir, J (2001) Probiotics-compensation for lactase insufficiency. American Journal of Clinical Nutrition 73 (2 Suppl), 421S–429S.CrossRefGoogle ScholarPubMed
Dhiman, RK, Sawhney, MS, Chawla, YK, Das, G, Ram, S & Dilawari, JB (2000) Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Digestive Disease and Science 45, 1549–1552.CrossRefGoogle ScholarPubMed
Droualt, S, Juste, C, Marteau, P, Renault, P & Corthier, G (2001) Genetically modified Lactococcus lactis expressing Staphylococcus hyicus lipase enhance lipid digestion in pigs with pancreatic insufficiency (abstract). Gastroenterology 20, G3642.Google Scholar
Elmer, GW, Surawicz, CM & McFarland, LV (1996) Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. Journal of the American Medical Association 275, 870–876.CrossRefGoogle ScholarPubMed
Felley, CP, Corthesy-Theulaz, I, Rivero, JL, Sipponen, P, Kaufmann, M, Bauerfeind, P, Wiesel, PH, Brassart, D, Pfeifer, A, Blum, AL & Michetti, P (2001) Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. European Journal of Gastroenterology and Hepatology 13, 25–29.CrossRefGoogle ScholarPubMed
Gionchetti, P, Rizzello, F, Venturi, A, Brigidi, P, Matteuzzi, D & Bazzocchi, G et al. , (2000 a) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305–309.CrossRefGoogle ScholarPubMed
Gionchetti, P, Rizzello, F, Venturi, A, Helwig, U, Amadini, C & Lammers, KM et al. , (2000 b) Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial (abstract). Gastroenterology 118, G1214.CrossRefGoogle Scholar
Guandalini, S, Pensabene, L, Zikri, MA, Dias, JA, Casali, LG, Hoekstra, H, Kolacek, S, Massar, K, Micetic-Turk, D, Papadopoulou, A, de Sousa, JS, Sandhu, B, Szajewska, H & Weizman, Z (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatrics Gastroenterology and Nutrition 30, 54–60.Google ScholarPubMed
Guslandi, M, Mezzi, G, Sorghi, M & Testoni, PA (2000) Saccharomyces boulardii in maintenance treatment of Crohn's disease. Digestive Diseases and Science 45, 1462–1464.CrossRefGoogle ScholarPubMed
Harms, HK, Bertele-Harms, RM & Bruer-Kleis, D (1987) Enzyme substitution therapy with the yeast Saccharomyces cerevisiae in congenital sucrase-isomaltase deficiency. New England Journal of Medicine 316, 1306–1309.CrossRefGoogle ScholarPubMed
Huber, JT (1997) Probiotics in cattle. In Probiotics, pp. 162–185 [Fuller, R, editor]. London: Chapman & Hall.CrossRefGoogle Scholar
Kaila, M, Isolauri, E, Saxelin, M, Arvilommi, H & Vesikari, T (1995) Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Archives of Diseases of Childhood 72, 51–53.CrossRefGoogle ScholarPubMed
Kruis, W, Schütz, E, Fric, P, Fixa, B, Judmaier, G & Stolte, M (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Alimentary Pharmacology and Therapeutics 11, 853–858.CrossRefGoogle ScholarPubMed
Malchow, HA (1997) Crohn's disease and Escherichia coli A new approach in therapy to maintain remission of colonic Crohn's disease? Journal of Clinical Gastroenterology 25, 653–658.CrossRefGoogle ScholarPubMed
Marteau, P, Flourié, B, Pochart, P, Chastang, C, Desjeux, JF & Rambaud, JC (1990) Role of the microbial lactase (EC 3.2.123) activity from yogurt on the intestinal absorption of lactose: an in vivo study in lactase deficient humans. British Journal of Nutrition 64, 71–79.CrossRefGoogle Scholar
Marteau, P & Flourie, B (2001) Tolerance to low-digestible carbohydrates: symptomatology and methods. British Journal of Nutrition 85 (Suppl 1), S17–S21.CrossRefGoogle ScholarPubMed
Marteau, PR, de Vrese, M, Cellier, CJ & Schrezenmeir, J (2001 a) Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition 73 (2 Suppl), 430S–436S.CrossRefGoogle ScholarPubMed
Marteau, P, Cuillerier, E, Gerhardt, MF, Myara, A, Bouvier, M, Bouley, C, Méance, S, Bommelaer, G & Grimaud, JC (2001 b) Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double blind randomised controlled study. Alimentary Pharmacology & Therapeutics. In press.Google Scholar
Marteau, P & Shanahan, F (2002) Role of antibiotics and probiotics in the management of inflammatory bowel disease. In Inflammatory Bowel Disease: From Bench to Bedside, 2nd edition. In press.Google Scholar
McFarland, LV, Surawicz, CM, Greenberg, RN, Fekety, R, Elmer, GW, Moyer, KA, Melcher, SA, Bowen, KE, Cox, JL & Noorani, Z et al. , (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Journal of the American Medical Association 271, 1913–1918.CrossRefGoogle ScholarPubMed
Michetti, P, Dorta, G, Wiesel, PH, Brassart, D, Verdu, E, Herranz, M, Felley, C, Porta, N, Rouvet, M, Blum, AL & Corthesy-Theulaz, I (1999) Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 60, 203–209.CrossRefGoogle ScholarPubMed
Mulder, R, Havenaar, R & Huis in't Veld, J (1997) Intervention strategies: the use of probiotics and competitive exclusion microfloras agaisnt contamination with pathogens in pigs and poultry. In Probiotics, pp. 186–208 [Fuller, R, editor]. London: Chapman & Hall.Google Scholar
Pool-Zobel, B, Van Loo, J, Rowland, I & Roberfroid, M (2002) Experimental evidences on the potential of prebiotic fructans to reduce the risk of cancer. British Journal of Nutrition 87, S273–S281, this issue.CrossRefGoogle Scholar
Rembacken, BJ, Snelling, AM, Hawkey, PM, Chalmers, DM & Axon, AT (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635–639.CrossRefGoogle ScholarPubMed
Roberfroid, M & Slavin, J (2000) Nondigestible oligosaccharides. Critical Review of Food Science and Nutrition 40, 461–480.CrossRefGoogle ScholarPubMed
Roncucci, L, Di Donato, P, Carati, L, Ferrari, A, Perini, M, Bertoni, G, Bedogni, G, Paris, B, Svanoni, F & Girola, M (1993) Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Diseases of the Colon and Rectum 36, 227–234.CrossRefGoogle ScholarPubMed
Rotstein, OD, Kay, RM, Wayman, M & Strasberg, SM (1981) Prevention of cholesterol gallstones by lignin and lactulose in the hamster. Gastroenterology 81, 1098–1103.CrossRefGoogle ScholarPubMed
Saavedra, JM, Bauman, NA, Oung, I, Perman, JA & Yolken, RH (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diahrroea and shedding of rotavirus. Lancet 344, 1046–1049.CrossRefGoogle ScholarPubMed
Schrezenmeir, J & de Vrese, M (2001) Probiotics, prebiotics, and synbiotics-approaching a definition. American Journal of Clinical Nutrition 73 (2 Suppl), 361S–364S.CrossRefGoogle ScholarPubMed
Shanahan, F (2001) Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120, 622–635.CrossRefGoogle ScholarPubMed
Surawicz, CM, McFarland, LV, Greenberg, RN, Rubin, M, Fekety, R, Mulligan, ME, Garcia, RJ, Brandmarker, S, Bowen, K, Borjal, D & Elmer, GW (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clinical Infectious Diseases 31, 1012–1017.CrossRefGoogle ScholarPubMed
Szajewska, H, Kotowska, M, Mrukowicz, JZ, Armanska, M & Mikolajczyk, W (2001) Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. Journal of Pediatrics 138, 361–365.CrossRefGoogle ScholarPubMed
Szilagyi, A (1998) Altered colonic environment, a possible predisposition to colorectal cancer and colonic inflammatory bowel disease: rationale of dietary manipulation with emphasis on disaccharides. Canadian Journal of Gastroenterology 12, 133–146.CrossRefGoogle ScholarPubMed
Weber, FL (1996) Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora. Digestive Disease 14 (Suppl 1), 53–63.CrossRefGoogle ScholarPubMed
Wollowski, I, Rechkemmer, G & Pool-Zobel, BL (2001) Protective role of probiotics and prebiotics in colon cancer. American Journal of Clinical Nutrition 73 (Suppl. 2), 451S–455S.CrossRefGoogle ScholarPubMed